Sibannac Takes Majority Stake in Apollo Wellness Centers

Sibannac disclosed it holds a 51% controlling interest in Apollo Wellness Centers, Inc., a joint venture with Doc-Rx.com, LLC formed under an agreement dated October 1, 2026. Apollo builds on Doc-Rx's operating telehealth platform, partner 503A compounding pharmacies, and US-made peptide supply chain, with plans to expand via licensed wellness clinics and its own peptides, nutraceuticals and medical foods line. The release includes no financial terms, revenue figures, or investment amount, and the revenue model (franchise-style clinic licensing) is entirely forward-looking.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.